Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Kim, Jeong Hyun ^a,f   Karpyak, Victor M ^b   Biernacka, Joanna M ^b   Nam, Hyung Wook ^a   Lee, Moonnoh R ^a   Preuss, Ulrich W ^c   Zill, Peter ^d   Yoon, Gihyun ^e   Colby, Colin ^b   Mrazek, David A ^b   Choi, Doo Sup ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MINNESOTA   (United States)

^f Sogang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; ISOLEUCINE; MESSENGER RNA; THREONINE; COMPLEMENTARY DNA; SLC29A1 PROTEIN, HUMAN;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CAUCASIAN; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; WILD TYPE; WITHDRAWAL SEIZURE; ALCOHOLISM; ANIMAL; CELL LINE; GENETICS; MOUSE MUTANT;

ANIMALIA; MUS;

ALCOHOL WITHDRAWAL SEIZURES; ALCOHOLISM; ANIMALS; CELL LINE; DNA, COMPLEMENTARY; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79551557906     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016331     Document Type: Article

References (51)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ (2002) Selected major risk factors and global and regional burden of disease. Lancet 360: 1347-1360.
2. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, et al. (1984) Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41: 949-958.
3. Harwood HJ, Fountain D, Livermore G (1998) Economic costs of alcohol abuse and alcoholism. Recent Dev Alcohol 14: 307-330.
4. Choi D-S, Karpyak VM, Frye MA, Hal-Flavin DK, Mrazek DA (2009) Drug Addiction, in Pharmacology and Therapeutics: Principles to Practice (Waldman SA, Terzic A, eds), Bermedica Production, Ltd. pp 817-835.
5. Liskow BI, Goodwin DW (1987) Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review. J Stud Alcohol 48: 356-370.
6. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173-184.
7. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24: 31-55.
8. Dar MS (1990) Central adenosinergic system involvement in ethanol-induced motor incoordination in mice. J Pharmacol Exp Therapeutics 255: 1202-1209.
9. Dar MS (1990) Functional correlation between subclasses of brain adenosine receptor affinities and ethanol-induced motor incoordination in mice. Pharmacol Biochem Behav 37: 747-753.
10. Boison D (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11: 25-36.
11. Boison D (2006) Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol Sci 27: 652-658.
12. Dragunow M (1991) Adenosine and seizure termination. Ann Neurol 29: 575.
13. Kaplan GB, Bharmal NH, Leite-Morris KA, Adams WR (1999) Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol 19: 157-162.
14. Boison D (2008) Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 8: 2-7.
15. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264.
16. Gordon AS, Collier K, Diamond I (1986) Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: An in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci USA 83: 2105-2108.
17. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS (1990) Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem 265: 1946-1951.
18. Sapru MK, Diamond I, Gordon AS (1994) Adenosine receptors mediate cellular adaptation to ethanol in NG108-15 cells. J Pharmacol Exp Therapeutics 271: 542-548.
19. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, et al. (2004) The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7: 855-861.
20. Chen J, Nam HW, Lee MR, Hinton DJ, Choi S, et al. (2010) Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Behav Brain Res 208: 636-642.
21. Wu J, Lee MR, Choi S, Kim T, Choi D-S (2010) ENT1 regulates ethanolsensitive EAAT2 expression and function in astrocytes. Alcohol Clin Exp Res 34: 1110-1117.
22. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, et al. (2003) Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A 100: 5896-5901.
23. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, et al. (2003) Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics 13: 297-301.
24. SenGupta DJ, Lum PY, Lai Y, Shubochkina E, Bakken AH, et al. (2002) A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry 41: 1512-1519.
25. Visser F, Sun L, Damaraju V, Tackaberry T, Peng Y, et al. (2007) Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnover. J Biol Chem 282: 14148-14157.
26. Hammond JR (2000) Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Naunyn-Sch Arch Pharmacology 361: 373-382.
27. Nam HW, Lee MR, Hinton DJ, Choi DS (2010) Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. Neurosci Lett 479: 277-281.
28. Rossetti ZL, Carboni S (1995) Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283: 177-183.
29. Levran O, Londono D, O'Hara K, Randesi M, Rotrosen J, et al. (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8: 531-540.
30. Hopp TP, Woods KR (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 78: 3824-3828.
31. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
32. Coe I, Zhang Y, McKenzie T, Naydenova Z (2002) PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett 517: 201-205.
33. Coe IR, Dohrman DP, Constantinescu A, Diamond I, Gordon AS (1996) Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J Pharmacol Exp Therapeutics 276: 365-369.
34. Bone DB, Robillard KR, Stolk M, Hammond JR (2007) Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2. Mol Membr Biol 24: 294-303.
35. Messing RO, Petersen PJ, Henrich CJ (1991) Chronic ethanol exposure increases levels of protein kinase C d and e and protein kinase C-mediated phosphorylation in cultured neural cells. J Biol Chem 266: 23428-23432.
36. Choi DS, Wang D, Dadgar J, Chang WS, Messing RO (2002) Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J Neurosci 22: 9905-9911.
37. Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, et al. (1999) Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat Neurosci 2: 997-1002.
38. Choi DS, Wei W, Deitchman JK, Kharazia VN, Lesscher HM, et al. (2008) Protein kinase Cdelta regulates ethanol intoxication and enhancement of GABA-stimulated tonic current. J Neurosci 28: 11890-11899.
39. Ballarin M, Fredholm BB, Ambrosio S, Mahy N (1991) Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 142: 97-103.
40. Nagel J, Hauber W (2002) Effects of salient environmental stimuli on extracellular adenosine levels in the rat nucleus accumbens measured by in vivo microdialysis. Behav Brain Res 134: 485-492.
41. Nagy LE, Diamond I, Collier K, Lopez L, Ullman B, et al. (1989) Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol 36: 744-748.
42. Schork NJ, Schork CM (1998) Issues and strategies in the genetic analysis of alcoholism and related addictive behaviors. Alcohol 16: 71-83.
43. Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, et al. (1998) Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry 155: 726-732.
44. Duka T, Gentry J, Malcolm R, Ripley TL, Borlikova G, et al. (2004) Consequences of multiple withdrawals from alcohol. Alcohol Clin Exp Res 28: 233-246.
45. Schmidt LG, Sander T (2000) Genetics of alcohol withdrawal. Eur Psychiatry 15: 135-139.
46. Schuckit MA, Tipp JE, Reich T, Hesselbrock VM, Bucholz KK (1995) The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 90: 1335-1347.
47. Banbury Conference on Genetic Background in Mice (1997) Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background. Neuron 19: 755-759.
48. Crusio WE, Goldowitz D, Holmes A, Wolfer D (2009) Standards for the publication of mouse mutant studies. Genes Brain Behav 8: 1-4.
49. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
50. Becker HC, Diaz-Granados JL, Hale RL (1997) Exacerbation of ethanol withdrawal seizures in mice with a history of multiple withdrawal experience. Pharmacology Biochemistry & Behavior 57: 179-183.
51. Che FY, Zhang X, Berezniuk I, Callaway M, Lim J, et al. (2007) Optimization of neuropeptide extraction from the mouse hypothalamus. J Proteome Res 6: 4667-4676.